STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXRX
  4. [144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Christopher Gibson (RXRX) files to sell 100,000 Class A shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A Form 144 notice reports that Christopher C. Gibson intends to sell up to 100,000 Class A shares of a NASDAQ-listed issuer through Fidelity Brokerage Services LLC. These shares are identified as Founders Shares acquired from the issuer on 04/20/2021 as compensation. The filing also lists multiple prior sales of Class A shares by Gibson, the Gibson Family Trust, and Lahwran-3 LLC during the past three months, each with specific share amounts and aggregate sale prices.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 100000 shares Class A shares proposed for sale through Fidelity Brokerage Services LLC
Proposed aggregate market value $325,410.00 Aggregate market value for 100,000 Class A shares proposed for sale
Proposed sale date 08/07/2026 Date associated with proposed NASDAQ sale of 100,000 Class A shares
Founders Shares grant date 04/20/2021 Date Founders Shares were acquired from issuer as compensation
Sale on 05/07/2026 40,000 shares; $134,800.00 Class A shares sold by Christopher C. Gibson during past three months
Sale on 06/18/2026 340,440 shares; $1,089,541.29 Large Class A sale by Christopher C. Gibson listed in past three months
Lahwran-3 LLC sale on 07/09/2026 186,000 shares; $706,094.96 Class A sale by Lahwran-3 LLC associated with Christopher C. Gibson
Form 144 regulatory
"144: Securities Information Class A | Fidelity Brokerage Services LLC"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Class A | 04/20/2021 | Founders Shares | Issuer |"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Compensation financial
"100000 | 04/20/2021 | Compensation"
Gibson Family Trust financial
"Gibson Family Trust 41 S Rio Grande Street Salt Lake City UT 84101"
Lahwran-3 Llc financial
"Lahwran-3 Llc 41 S Rio Grande Street Salt Lake City UT 84101"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the Form 144 filing for RXRX disclose about planned sales?
The Form 144 filing discloses a plan to sell 100,000 Class A shares through Fidelity Brokerage Services. These shares are Founders Shares originally received from the issuer as compensation on 04/20/2021, with the proposed sale date listed as 08/07/2026.

Who is the insider selling RXRX Class A shares in this Form 144?
The Form 144 identifies Christopher C. Gibson, based in Salt Lake City, Utah, as the seller of Class A shares. Related entities, including the Gibson Family Trust and Lahwran-3 LLC, are also listed as sellers of Class A shares over the past three months.

How many RXRX Class A shares are planned for sale under this Form 144?
The filing shows a proposed sale of 100,000 Class A shares. The securities information section lists 100,000 shares with an aggregate market value of $325,410.00 and a proposed sale date of 08/07/2026 on NASDAQ.

What are Founders Shares mentioned in the RXRX Form 144 filing?
The Form 144 describes the securities as Founders Shares of Class A stock. It states these shares were obtained directly from the issuer on 04/20/2021 as compensation, indicating an initial grant rather than open-market purchases.

What prior RXRX share sales by Christopher C. Gibson are listed?
The filing lists multiple past three-month sales, including 40,000 Class A shares for $134,800.00 on 05/07/2026 and 340,440 shares for $1,089,541.29 on 06/18/2026, along with numerous additional Class A transactions in July and early August 2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR